Labroots

A Gene Editor to Correct a Common Cystic Fibrosis Mutation

Cystic fibrosis (CF) is a common genetic disorders that has been well studied. Researchers have identified CF-causing mutations in a gene called CFTR, which encodes for an ion channel. The genetic ...
IFLScience on MSN

You’ve heard of mRNA, now there’s tRNA – potential gene therapy of the future for thousands with incurable diseases

What you’ll discover in this article ・tRNA-based treatments are a promising approach for genetic diseases caused by nonsense ...
Hosted on MSN

Gene therapy targets rare cystic fibrosis mutation affecting ~10%

For roughly one in ten people living with cystic fibrosis, the drugs that have transformed survival for most CF patients are useless. These individuals carry what scientists call a nonsense mutation ...
Medical Xpress

Cystic fibrosis: Expert explains symptoms, treatments, causes and more

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person. An autosomal recessive disorder ...
Yahoo Finance

Cystic Fibrosis Foundation Commits Up to an Additional $24 Million for Prime Medicine to Develop Gene Editing Therapy

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Healio

Q&A: Finding a treatment for rare cystic fibrosis splicing mutation

Please provide your email address to receive an email when new articles are posted on . Few patients with cystic fibrosis have a copy of the 3849+10kb C-to-T splicing mutation. Research is planned to ...
Yahoo

Genetic medicine can leave people with rare mutations behind. But there's new hope

Add Yahoo as a preferred source to see more of our stories on Google. This photo provided by Emily’s Entourage in April 2025 shows Emily Kramer-Golinkoff, who has cystic fibrosis caused by a rare ...
Business Wire

Cystic Fibrosis Foundation Funds Up to $15 Million to Prime Medicine to Pursue Gene Editing in CF

Prime Medicine’s prime editing technology has the potential to bring genetic therapies to all people with cystic fibrosis, ultimately paving the way to a cure. BETHESDA, Md.--(BUSINESS WIRE)--Today, ...
Drug Target Review

Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis

A preclinical study combining chemically modified suppressor tRNAs with inhaled lipid nanoparticles has restored functional ...
Nasdaq

Vertex Announces US FDA Approval of ALYFTREK™, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

- ALYFTREK™ is approved for patients 6 years and older with at least one responsive mutation, including 31 additional mutations not responsive to other CFTR modulator therapies - - In head-to-head ...
The Scientist

A Gene Editing System Corrects Cystic Fibrosis Mutation

An optimized version of prime editing technology raises the possibility of a one-time treatment for cystic fibrosis. In their 2019 paper, Liu’s team used prime editing to alter the gene mutations ...